Display options
Share it on

Sci Rep. 2021 Oct 21;11(1):20750. doi: 10.1038/s41598-021-00290-x.

De novo electrocardiographic abnormalities in persons living with HIV.

Scientific reports

Andreas D Knudsen, Claus Graff, Jonas Bille Nielsen, Magda Teresa Thomsen, Julie Høgh, Thomas Benfield, Jan Gerstoft, Lars Køber, Klaus F Kofoed, Susanne D Nielsen

Affiliations

  1. Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark.
  2. Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  3. Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
  4. Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
  5. Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  6. Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Blegdamsvej 9B, 2100, Copenhagen, Denmark. [email protected].

PMID: 34675281 PMCID: PMC8531322 DOI: 10.1038/s41598-021-00290-x

Abstract

Persons living with HIV (PLWH) may have increased incidence of cardiovascular events and longer QTc intervals than uninfected persons. We aimed to investigate the incidence and risk factors of de novo major electrocardiogram (ECG) abnormalities and QTc prolongation in well-treated PLWH. We included virologically suppressed PLWH without major ECG abnormalities, who attended the 2-year follow-up in the Copenhagen comorbidity in HIV infection (COCOMO) study. ECGs were categorized according to Minnesota Code Manual. We defined de novo major ECG abnormalities as new major Minnesota Code Manual abnormalities. Prolonged QTc was defined as QTc > 460 ms in females and QTc > 450 ms in males. Of 667 PLWH without major ECG abnormalities at baseline, 34 (5%) developed de novo major ECG abnormalities after a median of 2.3 years. After adjustment, age (RR: 1.57 [1.08-2.28] per decade older), being underweight (RR: 5.79 [1.70-19.71]), current smoking (RR: 2.34 [1.06-5.16]), diabetes (RR: 3.89 [1.72-8.80]) and protease inhibitor use (RR: 2.45 [1.27-4.74) were associated with higher risk of getting de novo major ECG abnormalities. Of PLWH without prolonged QTc at baseline, only 11 (1.6%) participants developed de novo prolonged QTc. Five percent of well-treated PLWH acquired de novo major ECG abnormalities and protease inhibitor use was associated with more than twice the risk of de novo major ECG abnormalities. De novo prolonged QTc was rare and did not seem to constitute a problem in well-treated PLWH.

© 2021. The Author(s).

References

  1. JAMA. 2005 Apr 20;293(15):1861-7 - PubMed
  2. JAMA. 2012 Apr 11;307(14):1497-505 - PubMed
  3. J Cardiovasc Electrophysiol. 2016 Oct;27(10):1206-1213 - PubMed
  4. J Am Heart Assoc. 2021 Feb 16;10(4):e018735 - PubMed
  5. Circulation. 2018 Sep 11;138(11):1100-1112 - PubMed
  6. Clin Infect Dis. 2015 May 1;60(9):1415-23 - PubMed
  7. Arch Intern Med. 2000 Jul 10;160(13):2050-6 - PubMed
  8. AIDS. 2018 Jun 19;32(10):1309-1316 - PubMed
  9. J Electrocardiol. 2011 Nov-Dec;44(6):779-85 - PubMed
  10. Eur Heart J. 2018 Sep 1;39(33):3021-3104 - PubMed
  11. J Geriatr Cardiol. 2019 Aug;16(8):630-638 - PubMed
  12. BMC Infect Dis. 2016 Nov 26;16(1):713 - PubMed
  13. J Infect Dis. 2010 Feb 1;201(3):318-30 - PubMed
  14. J Am Coll Cardiol. 2012 May 22;59(21):1891-6 - PubMed
  15. AIDS. 2017 Nov 28;31(18):2503-2514 - PubMed
  16. AIDS. 2019 Nov 15;33(14):2205-2210 - PubMed
  17. Circulation. 1999 Aug 17;100(7):700-5 - PubMed
  18. Arch Intern Med. 2007 Sep 10;167(16):1720-8 - PubMed
  19. Eur Heart J. 2012 Apr;33(7):875-80 - PubMed
  20. Eat Weight Disord. 2019 Apr;24(2):199-207 - PubMed
  21. Eur J Prev Cardiol. 2012 Dec;19(6):1430-6 - PubMed
  22. J Am Heart Assoc. 2016 Mar 14;5(3):e002882 - PubMed
  23. Lancet. 2002 Nov 30;360(9347):1747-8 - PubMed
  24. J Infect. 2007 Jun;54(6):597-602 - PubMed
  25. J Am Heart Assoc. 2017 Oct 5;6(10): - PubMed

Publication Types